Importantly, the MLL fusion proteins have been associated with an oncogenic role due to their ability to initiate the tumorigenic process in both AML and acute lymphoblastic leukemia (ALL) cells (Cozzio et al., 2003; Krivtsov et al., 2006; Somervaille et al., 2009). This evidence concerns the gene KMT2A and acute lymphoblastic leukemia.